UTI Healthcare Fund - Regular Plan - Growth Option

(Erstwhile UTI Pharma & Healthcare Fund-Growth Option)
Fund House: UTI Mutual Fund
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 05-08-2005
Asset Class: Equity
Benchmark: S&P BSE Healthcare TRI
Expense Ratio: 2.48% As on (30-09-2022)
Status: Open Ended Schemes
Minimum Investment: 5000.0
Minimum Topup: 1000.0
Total Assets: 725.41 Cr As on (31-10-2022)
Turn over: 35% | Exit Load: 1% for redemption within 30 days

153.7047

13.11%

PERFORMANCE

Returns Type:
of  
Start :  
End : 
Period:  
This Scheme
-
vs
NIFTY 50 TRI
-
Gold
-
PPF
-
Returns Type:
of  
  Period:  

Start :  
Period:  

RETURNS ANALYSIS

Fund Multiplier

Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)

Time Taken To Multiply
2x
4x
5x
10x
FUND
0 Years 4 Months
5 Years 2 Months
7 Years 9 Months
9 Years 8 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months

 

Investment Objective

An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.

Current Asset Allocation (%)

Indicators

Volatility 15.99
Sharp Ratio 0.92
Alpha 1.44
Beta 0.93
Yield to Maturity -
Average Maturity -

PEER COMPARISON

Scheme Name Inception
Date
1 Year
Return(%)
2 Year
Return(%)
3 Year
Return(%)
5 Year
Return(%)
10 Year
Return(%)
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 -5.98 7.3 21.73 12.22 12.65
SBI Healthcare Opportunities Fund - Regular Plan -Growth 14-07-1999 1.93 11.39 24.31 12.53 14.58
DSP Healthcare Fund - Regular Plan - Growth 05-11-2018 -0.89 11.33 27.8 - -
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 -1.38 - - - -
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 05-07-2018 -1.78 9.89 24.08 - -
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 28-12-2015 -2.1 10.28 22.5 14.64 -
Nippon India Pharma Fund-Growth Plan-Growth Option 01-06-2004 -3.69 10.91 24.43 16.45 15.62
Mirae Asset Healthcare Fund -Regular Growth 10-07-2018 -4.84 11.76 26.5 - -
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 05-07-2019 -6.25 7.59 18.7 - -
IDBI Healthcare Fund - Regular Plan - Growth 22-02-2019 -6.73 4.99 18.1 - -

Scheme Characteristics

Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.

Riskometer

riskometer

PORTFOLIO

Market Cap Distribution

Small Cap

27.46%

Others

1.98%

Large Cap

45.18%

Mid Cap

25.39%

Tax Benefits of investing in this fund

Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#

Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.

Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **

# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund

Feedback
Notification